Optimizing next-generation sequencing for precision oncology trials

The advancement of precision medicine is revolutionizing cancer care by tailoring treatments to individual patients based on their tumor’s genetic profile. This personalized approach significantly enhances diagnosis, treatment planning and prognosis determinations.

To succeed in this evolving field, drug developers need a deep understanding of the common challenges. Sponsors that are able to efficiently leverage next-generation sequencing (NGS) technologies can address challenges such as patient recruitment, tissue sample limitations and rapid result turnaround.
This white paper explores the NGS strategies that drive success in precision oncology, providing insights into overcoming common obstacles and improving patient outcomes.